Scholars Central

Conference abstractPublished 3 Aug 2015

Synthesis and in vitro cytotoxic activity of novel pyrazolo [1,5-a]pyrimidines towards breast adenocarcinoma MCF-7 cell line, cell cycle analysis and QSAR studies

Authors: Magda M F Ismail

Azhar University, Egypt

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The cyclin-dependent kinases (CDKsa) are a family of serine/threonine protein kinases that play essential roles in the regulation of cell division. Individual CDKs phosphorylate distinct substrates in different phases of the cell cycle. Motivated by the widely reported anticancer activity of 4 arylazo-3,5-diamino-1H-pyrazoles as a novel cytotoxic agents against CDK2- cyclin E, new series of 3,5-diamino-4-arylazopyrazoles (3,4), were synthesized by cycloaddition of N2H4 on aryl(diazenyl) malononitrile 1 in 1:1 or 1:2 molar ratios. In addition, 5,7-diarylpyrazolo[1,5-a] pyrimidines possessing CDK2 inhibitory activity have been reported. Herein, we described the synthesis of 2-amino-3-arylazopyrazolo[1,5-a]pyrimidine derivatives (5-18) by reflux of 3,4 with ethoxymalononitrile, chalcones or arylidinemalononitriles in EtOH/Pip. 16 compounds were evaluated for the in vitro cytotoxic activityagainst human breast adenocarcinoma MCF-7cell line using MTT technique. Some of the tested compounds exploited moderate growth inhibitory activity (IC50âÂ?Â?s = 15.32-40.70 Ã?¼M); in particular compound 7 exhibited superior potency (IC50 = 3.25 Ã?¼M). Its effect was furtherstudied on cell cycle progression. A significantincrease in the percentage of cells at S-phase by 1.4 folds compared to control which indicates that the mechanism of action is related to S cell cycle arrest. Molecular docking simulation was also carried out for CDK2 enzyme to investigate their binding affinity. A 2D QSAR model was builtto explore the structural requirements controlling the observed cytotoxic properties.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Magda M F Ismail”